Sanofi · 1 day ago
Global Brand Manager, Nuvaxovid- Vaccines
Sanofi is an R&D-driven, AI-powered biopharma company committed to improving people’s lives and delivering compelling growth. The Global Brand Manager will be responsible for the co-development and implementation of the marketing strategy for the Nuvaxovid global brand, managing advertising agencies and driving digital strategies to support global launches.
Health CareLife SciencePharmaceuticalTherapeutics
Responsibilities
Lead the Nuvaxovid cross-functional global brand team to assess, update and implement a comprehensive brand plan that will grow awareness and adoption of Nuvaxovid globally
Drive brand priorities with strong management and coordination with the advertising agency to prepare cross-functional teams globally and locally to execute
Shape the digital/omnichannel strategy and key tactics with key launch markets and the wider Flu franchise to ensure consistency
Demonstrate ownership to improve outcomes, processes, collaboration and increase personal impact by proactively engaging in efforts to improve job performance, individually and for the Global Brand Team
The Global Brand Manager will assist to bring brand marketing expertise and assist the creation, development, and execution of a long-term brand strategy (capturing the product’s value, identifying opportunities, and fostering target activation throughout the product lifecycle)
He/she will contribute to brand marketing strategy and ensure its relevance along the life of the product, assisting in the definition of the global customer segmentation and the messaging strategy
The GBM will support deployment of the global strategy for key GBT markets
Qualification
Required
At least 8 years of experience as a global/regional/local marketer
Minimum of a bachelor's degree is required for the role
Strong strategic thinking skills and ability to develop an actionable brand strategy and ensure its operationalization at country level
Previous experience in leading cross-functional teams
Excellent oral and written communication skills, including ability to synthetize and deliver clear and impactful presentation to senior management
Experience/Good understanding of mature markets dynamics (North America, EU, and Japan)
Required to have core knowledge about all commercial topics such as market/customer segmentation, omni-channel activation, comm agency management, external stakeholder engagement, competitive intel, payer systems, etc
Language: English (native or very fluent)
Impact-driven solution-oriented leader with strong business acumen
Strong leadership skills with proven ability to provide clear directions, drive alignment with other functions, make decision/arbitrage in a timely manner and drive/track execution
Be comfortable navigating ambiguity and managing conflicts
Ability to develop strong relationships and achieve positive impact & influence without authority
Ability to prioritize and maintain focus on most business-critical activities
Ability to work in a fast-paced environment, work with uncertainty, and quickly adjust to changing priorities
Preferred
MBA or Master's degree in a business school
Previous experience in vaccines or seasonal vaccines (like Flu)
Previous GBM experience in the GloCal model
Scientific or Medical background (Pharm D or PhD)
Language: French
Benefits
High-quality healthcare
Prevention and wellness programs
At least 14 weeks’ gender-neutral parental leave
Company
Sanofi
Sanofi is a global biopharma company focused on prescription drugs, vaccines, and treatments for chronic, rare, and infectious diseases.
H1B Sponsorship
Sanofi has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (101)
2024 (68)
2023 (59)
2022 (78)
2021 (38)
2020 (38)
Funding
Current Stage
Public CompanyTotal Funding
$6.97BKey Investors
Blackstone Life SciencesEvotec
2025-10-28Post Ipo Debt· $3B
2025-06-17Post Ipo Debt· $1.74B
2025-03-05Post Ipo Debt· $1.59B
Recent News
2026-01-06
BioWorld Financial Watch
2026-01-06
2026-01-06
Company data provided by crunchbase